Table 2.
Phase 3 trials comparing high-dose therapy (HDT) with conventional chemotherapy (Chemo) as frontline therapy for multiple myeloma
View large
Phase 3 trials comparing high-dose therapy (HDT) with conventional chemotherapy (Chemo) as frontline therapy for multiple myeloma

V indicates vincristine; M, melphalan; C, cyclophosphamide; P, prednisone; B, carmustine; and A, Adriamycin.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal